Search
Latest topics
D2-40 Expression in Primary Scarring and Nonscarring Alopecia
Page 1 of 1 • Share •
D2-40 Expression in Primary Scarring and Nonscarring Alopecia
Am J Dermatopathol. 2010 Apr 20.
D2-40 Expression in Primary Scarring and Nonscarring Alopecia.
Mahalingam M, Hoang MP.
From the *Dermatopathology Section, Department of Dermatology, Boston University School of Medicine; and daggerDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Abstract
The pathogenesis of scarring alopecia is believed to be related to damage to stem cells within, and outside the confines of, the follicular bulge region. Scattered reports indicate that D2-40, a monoclonal antibody that specifically detects a fixation-resistant epitope on podoplanin, highlights the basal cell layer of the outer root sheath. Given this, we sought to ascertain involvement of the same in a total of 52 cases of alopecia (33 scarring and 19 nonscarring). D2-40 expression, noted in the peripheral layer of the outer root sheath (above and below attachment of the pilar muscle), was similar in 24/33 (73%) and increased in 9/33 (27%) in the infundibular region of cases of scarring alopecia in comparison to its expression in 17/19 (90%; no expression noted in the other 2) of cases of nonscarring alopecia. The absence of a unifying diagnosis in entities demonstrating an increase precludes any correlation from being made regarding D2-40 expression and histologic diagnosis. However, more recently, podoplanin has been shown to be a novel Fos target gene in some skin cancers. Thus, from a scientific perspective, involvement of Fos-dependent transcription mechanisms in the etiopathogenesis of select scarring alopecias does not seem entirely unreasonable although studies defining the role of the Fos-podoplanin axis in development of the normal hair follicle are required before a definitive conclusion can be drawn.
D2-40 Expression in Primary Scarring and Nonscarring Alopecia.
Mahalingam M, Hoang MP.
From the *Dermatopathology Section, Department of Dermatology, Boston University School of Medicine; and daggerDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Abstract
The pathogenesis of scarring alopecia is believed to be related to damage to stem cells within, and outside the confines of, the follicular bulge region. Scattered reports indicate that D2-40, a monoclonal antibody that specifically detects a fixation-resistant epitope on podoplanin, highlights the basal cell layer of the outer root sheath. Given this, we sought to ascertain involvement of the same in a total of 52 cases of alopecia (33 scarring and 19 nonscarring). D2-40 expression, noted in the peripheral layer of the outer root sheath (above and below attachment of the pilar muscle), was similar in 24/33 (73%) and increased in 9/33 (27%) in the infundibular region of cases of scarring alopecia in comparison to its expression in 17/19 (90%; no expression noted in the other 2) of cases of nonscarring alopecia. The absence of a unifying diagnosis in entities demonstrating an increase precludes any correlation from being made regarding D2-40 expression and histologic diagnosis. However, more recently, podoplanin has been shown to be a novel Fos target gene in some skin cancers. Thus, from a scientific perspective, involvement of Fos-dependent transcription mechanisms in the etiopathogenesis of select scarring alopecias does not seem entirely unreasonable although studies defining the role of the Fos-podoplanin axis in development of the normal hair follicle are required before a definitive conclusion can be drawn.
_________________
http://www.immortalhair.org/mycurrentregimen.htm
Now available for consultation (hair and/or health)
http://www.immortalhair.org/consultation.htm

CausticSymmetry- Admin
- Posts: 8401
Join date: 2008-07-09

Re: D2-40 Expression in Primary Scarring and Nonscarring Alopecia
IH -- Can you translate this to English, lol? I'm interested in what it means.
hadrion- Posts: 608
Join date: 2008-07-09
Re: D2-40 Expression in Primary Scarring and Nonscarring Alopecia
i'd like to know more about it as well... is there any particular regimen formed to treat it?
D2-40 expression is found in to be serious factor also in different diseases. Crohn's disease for example.
Scary thougth i have 2 scars on my head yet from my teens. Doctors said i was hit, of course that's not true. Bad to is worse - i until recently believed it was regular alopecia areata... Any thought will be welcome.
D2-40 expression is found in to be serious factor also in different diseases. Crohn's disease for example.
Scary thougth i have 2 scars on my head yet from my teens. Doctors said i was hit, of course that's not true. Bad to is worse - i until recently believed it was regular alopecia areata... Any thought will be welcome.

Beebrox- Posts: 136
Join date: 2011-11-19
Similar topics» D2-40 Expression in Primary Scarring and Nonscarring Alopecia
» Follicular streamers (stelae) in scarring and non-scarring alopecia
» IH -- Actos, a diabetes drug being used for scarring alopecia
» The expression of hepatocyte growth factor (HGF) family genes is reduced in hair follicles from androgenetic alopecia
» Scarring alopecia and the PPAR-gamma connection
» Follicular streamers (stelae) in scarring and non-scarring alopecia
» IH -- Actos, a diabetes drug being used for scarring alopecia
» The expression of hepatocyte growth factor (HGF) family genes is reduced in hair follicles from androgenetic alopecia
» Scarring alopecia and the PPAR-gamma connection
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum



» New Paradigm Shift - PEO's (not EFA's)
» Grow New Hair! (The original Papilla Power??)
» Diatomaceous earth for hair loss?
» Hair loss, inflammation and pustules on scalp, doctors can't identify
» New Ray Peat Discussion thread
» PGD2 proven to be implicated as a cause of baldness
» The Fallacy Of Blood Flow As A Non Factor In Balding.... And What To Do About it...
» Is baldness really linked to diseases?